Forbes William P — SEC insider filings

SEC reporting owner CIK 1314760. 39 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2021-02-03 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
HERON THERAPEUTICS, INC. /DE/ (HRTX)EVP, Chief Development Officer262 legs · 75,000 sh · $74,245—60
Beyond Air, Inc. (XAIR)Director92 legs · 10,000 sh · $65,650—35
Trevi Therapeutics, Inc. (TRVI)Chief Development Officer4——4

Insider filings — Forbes William P

FiledFormIssuerReported transactionsSource
2026-11-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,770 · Tax withholding (F): 3,349 @ $0.28 · Option exercise (M): 11,695 · Tax withholding (F): 3,327 @ $0.28 · Option exercise (M): 11,770 (derivative) @ $0 · Option exercise (M): 11,695 (derivative) @ $0EDGAR
2026-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Tax withholding (F): 1,102 @ $0.36 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2026-08-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,769 · Tax withholding (F): 3,348 @ $0.50 · Option exercise (M): 11,694 · Tax withholding (F): 3,326 @ $0.50 · Option exercise (M): 11,769 (derivative) @ $0 · Option exercise (M): 11,694 (derivative) @ $0EDGAR
2026-07-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Tax withholding (F): 1,101 @ $0.47 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2026-06-084HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2026-05-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,694 · Option exercise (M): 11,770 · Option exercise (M): 11,694 (derivative) @ $0 · Option exercise (M): 11,770 (derivative) @ $0EDGAR
2026-04-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 188,315 (derivative) @ $0 · Grant/award (A): 188,314 (derivative) @ $0EDGAR
2026-01-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0EDGAR
2025-11-064Beyond Air, Inc. (XAIR)Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 400 (derivative) · Grant/award (A): 400 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · +10 moreEDGAR
2025-11-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0EDGAR
2025-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2025-08-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0EDGAR
2025-07-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2025-06-094HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2025-05-024HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0EDGAR
2025-04-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0EDGAR
2025-03-284Beyond Air, Inc. (XAIR)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-02-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 374,220 (derivative) @ $0 · Grant/award (A): 187,110 (derivative) @ $0EDGAR
2025-01-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2024-11-264Beyond Air, Inc. (XAIR)Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Grant/award (A): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · +8 moreEDGAR
2024-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2024-07-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0EDGAR
2024-06-074HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2024-04-194HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0EDGAR
2024-03-214Beyond Air, Inc. (XAIR)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-01-194HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 371,935 (derivative) @ $0 · Grant/award (A): 61,989 (derivative) @ $0EDGAR
2023-11-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Purchase (P): 25,000 @ $1.09EDGAR
2023-11-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Purchase (P): 50,000 @ $0.94EDGAR
2023-04-034Beyond Air, Inc. (XAIR)Purchase (P): 5,000 @ $6.67EDGAR
2023-03-314Beyond Air, Inc. (XAIR)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-03-204Beyond Air, Inc. (XAIR)Purchase (P): 5,000 @ $6.46EDGAR
2022-07-014/ATrevi Therapeutics, Inc. (TRVI)Grant/award (A): 137,500 (derivative) @ $0EDGAR
2022-07-014Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 48,000 (derivative) @ $0EDGAR
2022-03-074Beyond Air, Inc. (XAIR)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-02-154Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 137,500 (derivative) @ $0EDGAR
2021-03-084Beyond Air, Inc. (XAIR)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-02-034Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1314760 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs